Portside Wealth Group LLC Sells 28,616 Shares of Haleon plc (NYSE:HLN)

Portside Wealth Group LLC reduced its holdings in Haleon plc (NYSE:HLN - Free Report) by 61.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,126 shares of the company's stock after selling 28,616 shares during the quarter. Portside Wealth Group LLC's holdings in Haleon were worth $173,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC bought a new stake in shares of Haleon during the 4th quarter worth $187,000. Spire Wealth Management purchased a new position in shares of Haleon in the fourth quarter valued at about $39,000. Greenleaf Trust raised its stake in shares of Haleon by 8.4% during the fourth quarter. Greenleaf Trust now owns 17,225 shares of the company's stock valued at $164,000 after acquiring an additional 1,333 shares during the last quarter. Mather Group LLC. boosted its holdings in shares of Haleon by 177.4% during the fourth quarter. Mather Group LLC. now owns 5,623 shares of the company's stock worth $54,000 after purchasing an additional 3,596 shares during the period. Finally, Bleakley Financial Group LLC grew its stake in shares of Haleon by 24.6% in the fourth quarter. Bleakley Financial Group LLC now owns 14,784 shares of the company's stock worth $141,000 after purchasing an additional 2,921 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors.

Haleon Stock Down 0.0%

NYSE:HLN traded down $0.01 during trading hours on Tuesday, reaching $10.88. 11,035,786 shares of the company traded hands, compared to its average volume of 8,808,321. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The business's 50-day moving average price is $10.52 and its two-hundred day moving average price is $10.05. Haleon plc has a 1 year low of $8.25 and a 1 year high of $11.42. The stock has a market capitalization of $48.97 billion, a P/E ratio of 31.99, a P/E/G ratio of 2.82 and a beta of 0.31.

Wall Street Analyst Weigh In

HLN has been the topic of a number of recent analyst reports. HSBC reiterated a "hold" rating on shares of Haleon in a research report on Wednesday, March 5th. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 target price for the company in a research report on Friday, May 9th. Hsbc Global Res downgraded shares of Haleon from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, March 5th. BNP Paribas raised Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. Finally, BNP Paribas Exane raised Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target on the stock in a research note on Tuesday, May 27th. Five analysts have rated the stock with a hold rating, five have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $12.33.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.